Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.

This study is not yet recruiting. It focuses on depression and currently lists study information in Global.
Leave your email and HopeStage can help you better understand this study.
This study is looking at whether From Fear to Purpose (Acceptance and Commitment Therapy) can help people with Death Anxiety, Depression, or Anxiety. Participants take part in From Fear to Purpose (Acceptance and Commitment Therapy) and complete follow-up assessments. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
The official record does not clearly spell out the visit format, but it appears to be coordinated directly by the research team. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually meeting the main study requirements, while common reasons not to take part include safety concerns that need urgent care first and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
Taking part may help improve understanding of your condition.
It requires regular follow-up, often through questionnaires or interviews.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with placebo. Direct benefit is not guaranteed.
This study is sponsored by Babes-Bolyai University. Based on the sponsor name or official registry information, it appears to be a university. You should verify the details in the official registry record.
This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me